18.400
+0,00%
2026-05-13
Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +73.9% | +125.5% | 3 / 3 | +41.5% | -5.08 pp | +0.80 pp | +6.6% | 0.14 | 10.46 | 123 | +41,5% | 5,3 | +73,9% | 10.46 | 27.47 | −61,9% |
| Pts | 12 | 12 | 12 | 12 | 0 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 18.400 (close price on 2026-05-13)EPS (TTM): 1.759
Financial charts
1.Revenue & growth
VND bn123Q2/26
1.Revenue & growth
VND bn123Q2/26
2.Profit & growth
VND bn5,29Q2/26
3.Profit mix (Penman)
VND bn28,2Q2/26
4.Margins & cost structure
%21.8%Q2/26
5.Returns & cash cycle
% · days7.0%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn463Q2/26
8.Funding & debt health
VND bn · times463Q2/26
9.Revenue backlog
VND bn16,1Q2/26
10.Valuation
times · %10,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %426Q2/26
Adjusted EPS growth, latest quarter
73.9%
Average adjusted EPS growth, 3 quarters
125%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26